Abstract
Purpose: The aim was to investigate which ovarian hyperstimulation protocol performed in the same patients causes development of oocytes of good quality.
Methods: Twenty normo-ovulatory women underwent three different controlled ovarian hyperstimulation protocols for in vitro fertilization–embryo transfer. Patients underwent follicle aspiration after administration of human chorionic gonadotropin (hCG). The total number of retrieved oocytes, the number of mature oocytes, and the rate of mature oocytes were examined. Recovered granulosa cells were stained with Hoechst 33258 and examined by fluorescence microscopy to estimate the incidence of apoptotic cells.
Results: The total number of oocytes and the number of mature oocytes in gonadotropin-releasing hormone agonist (GnRHa) + human menopausal gonadotropin (hMG) + hCG and hMG + hCG cycles were higher than those in the natural cycle (P < 0.0001). The rate of mature oocytes in hMG + hCG cycle was the highest among the three protocols (P < 0.04). In the mural granulosa cells, the incidence of apoptotic cells in the GnRHa + hMG + hCG cycle was significantly higher than those of the natural (P < 0.002) and hMG + hCG cycles (P = 0.0002). The incidence of apoptotic cumulus granulosa cells in the GnRHa + hMG + hCG cycle was significantly higher than those of natural and hMG + hCG cycles (P < 0.002). Moreover, the incidence of apoptotic cumulus granulosa cells in the hMG + hCG cycle was significantly lower than that in the natural cycle (P < 0.01).
Conclusions: These results indicated that hMG + hCG is the most appropriate controlled ovarian hyperstimulation protocol among the three examined with regard to oocyte quality.
Similar content being viewed by others
REFERENCES
Garcia JE, Jones GS, Acosta AA, Wrigt G: Human menopausal gonadotropin/human chorionic gonadotropin follicular maturation for oocyte aspiration: Phase 1. Fertil Steril 1983;39:174-179
Laufer N, DeCherney AH, Haseltine FP, Polan ML, Mezer HC, Dlugi AM, Sweeney D, Nero F, Naftolin F: The use of high-dose human menopausal gonadotropin in an in vitro fertilization program. Fertil Steril 1984;40:734-741
DeCherney AH, Tarlatzis BC, Laufer N: Follicular development: Lessons learned from human in vitro fertilization. Am J Obstet Gynecol 1985;153:911-923
Porter RN, Smith W, Craft IL, Abdulwahid NA, Jacobs HS: Induction of ovulation for in vitro fertilization using buserelin and gonadotropins. Lancet 1984;2:1284-1285
Fleming R, Haxton MJ, Yates RWS: A simple procedure for the induction of multiple follicular growth with blockade of LH surge in normal women. In Program and Abstracts of the Annual Meeting of the Endocrine Society. Baltimore, Maryland, 1985, pp
Nader S, Berkowitz AS, Maklad N, Wolf DP, Held B: Characteristics of patients with and without gonadotropin surges during follicular recruitment in an in vitro fertilization/embryo transfer program. Fertil Steril 1986;45:75-78
Rutherford AJ, Subak-Sharpe RJ, Dawson KJ, et al.: Improvement of in vitro fertilization after treatment with buserelin, an agonist of luteinising hormone releasing hormone. Br Med J 1988;296:1765-1768
Billig H, Furuta I, Hsueh AJW: Gonadotropin-releasing hormone directly induces apoptotic cell death in the rat ovary: Biochemical and in situ detection of deoxyribonucleic acid fragmentation in granulosa cells. Endocrinology 1994; 134:245-252
Testart J, Belaisch-Allart J, Frydman R: Relationship between embryo transfer results and ovarian response and in-vitro fertilization rate: Analysis of 186 human pregnancies. Fertil Steril 1986;45:237-243
Testart J, Belaisch-Allart JC, Forman R, Gazengel A, Strubb N, Hazout A, Strubb N, Frydman R: Influence of different stimulation treatment on oocyte characteristics and in-vitro fertilizing ability. Human Reprod 1989;4:22-29
Tilly JL, Kowalski KI, Johnson AL, Hsueh AJW: Involvement of apoptosis in ovarian follicular atresia and postovulatory regression. Endocrinology 1991;129:2799-2801
Piquette GN, Tilly JL, Prichard L, Simon C, Polan ML: Detection of apoptosis in human and rat ovarian follicles. J Soc Gynecol Invest 1994;1:297-301
Leoncini L, Del Vecchio MT, Megha T, Barbini P, Galieni P, Pileri S, Sabattini E, Gherlinozi F, Tosi P, Kraft R, Cotier H: Correlation between apoptotic and proliferative indices in malignant non-Hodgkin's lymphoma. Am J Pathol 1993;142:755-763
Wheeler TM, Rogers E, Aihara M, Scardino PT, Thompson TC: Apoptotic index as a biomaker in prostatic intraepithelial neoplasma (PIN) and prostatic cancer. J Cell Biol 1994;19:202-207
Nakahara K, Saito H, Saito T, Ito M, Ohta N, Sakai N, Tezuka N, Hiroi M: Incidence of apoptotic bodies in membrana granulosa of the patients participating in an in vitro fertilization programs. Fertil Steril 1997;67:302-308
Nakahara K, Saito H, Saito T, Ito M, Ohta N, Takahashi T, Hiroi M: Incidence of apoptotic bodies in membrana granulosa can predict prognosis of ova from patients participating in in vitro fertilization programs. Fertil Steril 1997;68:312-317
Nakahara K, Saito H, Saito T, Ito M, Ohta N, Takahashi T, Hiroi M: Ovarian fecundity in patients with endometriosis can be estimated by the incidence of apoptotic bodies. Fertil Steril 1998;69:931-935
Saito H, Hiroi M: Correlation between the follicular gonadotropin inhibitor and the maturity of ovum-corona-cumulus complex. Fertil Steril 1986;46:66-72
Neveu S, Hedon B, Bringer J, Chinchole JM, Arnal F, Humeau C, Cristol P, Viala JL: Ovarian stimulation by a combination of gonadotropin-releasing hormone agonist and gonadotropins for in vitro fertilization. Fertil Steril 1987;47:639-643
Ashkenazi J, Dicker D, Feldberg D, Goldman GA, Yeshaya A, Goldman JA: The value of GnRH analogue therapy in Journal of Assisted Reproduction and Genetics, Vol. 17, No. 10, 2000 IVF in women with unexplained infertility. Hum Reprod 1989;4:667-669
Zhao S, Saito H, Wang X, Saito T, Kaneko T, Hiroi M: Effects of gonadotropin-releasing hormone agonist on the incidence of apoptosis in porcine and human granulosa cells. Gynecol Obstet Invest 2000;49:52-56
Saito S, Saito H, Yanasaki E, Hosoi E, Komatsu M, Iwahana H, Maeda T: Radioimmunoassay of an analog of luteinizing hormone-releasing hormone, [D-Ser (tBu)]6 des-Gly-NH2 10 ethylamide (Buserelin). Immunol Methods 1985;79:173-183
Friedman CI, Schmidt CE, Chang FE, Kim MH: Severe ovarian hyperstimulation following follicular aspiration. Am J Obstet Gynecol 1984;150:436-437
Serhal PF, Katz M, Little V, Woronowski H: Unexplained infertility-The value of Pergonal superovulation combined with intrauterine insemination. Fertil Steril 1988;49:602-606
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kaneko, T., Saito, H., Takahashi, T. et al. Effects of Controlled Ovarian Hyperstimulation on Oocyte Quality in Terms of the Incidence of Apoptotic Granulosa Cells. J Assist Reprod Genet 17, 580–585 (2000). https://doi.org/10.1023/A:1026439409584
Issue Date:
DOI: https://doi.org/10.1023/A:1026439409584